AKT1 and colorectal cancer: In addition, PIK3CA mutation-induced PI3K/Akt activation contributes to the survival and proliferation of colorectal cancer stem cells, further leading to chemoresistance (Wang et al., 2018a), and promoting epithelial-mesenchymal transition by regulating AKT activity (Miller et al., 2020).